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Heparan sulfate (HS) chains play crucial biological roles by binding to various signaling molecules
including ﬁbroblast growth factors (FGFs). Distinct sulfation patterns of HS chains are required
for their binding to FGFs/FGF receptors (FGFRs). These sulfation patterns are putatively regulated
by biosynthetic enzyme complexes, called GAGOSOMES, in the Golgi. While the structural require-
ments of HS–FGF interactions have been described previously, it is still unclear how the FGF-binding
motif is assembled in vivo. In this study, we generated HS structures using biosynthetic enzymes in a
sequential or concurrent manner to elucidate the potential mechanism by which the FGF1-binding
HS motif is assembled. Our results indicate that the HS chains form ternary complexes with FGF1/
FGFR when enzymes carry out modiﬁcations in a speciﬁc manner.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heparan sulfate (HS) is a linear, sulfated polysaccharide that
consists of repeating units of glucosamine (GlcN) and glucuronic
acid (GlcA) or iduronic acid (IdoA). As the nascent HS undergoes
elongation, a series of modiﬁcations occurs on the backbone.
N-acetyl glucosamine (GlcNAc) residues are N-deacetylated and
N-sulfated by N-deacetylase-N-sulfotransferase (NDST), whereas
GlcA residues are epimerized to IdoA by C5-epimerase. Addition-
ally, a variety of O-sulfotransferases (OST) can add sulfate groups
to the C6 (6-OST) and C3 (3-OST) carbons of GlcN residues and
the C2 carbon (2-OST) of IdoA residues. It is also possible for
2-OST to add sulfate groups, albeit less preferentially, to the C2
carbon of GlcA residues [1]. To further augment this structural
diversity, HS has a domain-like architecture composed of highly
sulfated domains (NS domains), non-sulfated domains (NA
domains), and partially sulfated domains (NA/NS domains). This
immense structural complexity is believed to regulate the interac-chemical Societies. Published by E
000 E, Skaggs Hall Room 307,
n).tions of HS with several protein targets including growth factors
and cytokines [2].
One of the most commonly studied HS–protein interactions is
that of HS and FGF. The FGF family plays a major role in several
fundamental biological processes including cell proliferation, cell
differentiation and cell migration [3,4]. Twenty two different FGFs
and four FGFR genes have been discovered in humans [4]. FGF1
(acidic FGF) and FGF2 (basic FGF) were the ﬁrst FGFs isolated
[5,6]. FGF1 is able to bind to all FGFRs while FGF2 can only bind
to FGFR1b, 1c, 2c, 3c and 4 [7]. HS potentiates FGF signaling by
acting as a co-receptor and facilitates the formation of biologically
relevant HS/FGF/FGFR ternary complexes. It facilitates the dimer-
ization of FGFRs and thereby regulates downstream signaling
pathways [8–10].
There have been many studies that have investigated the struc-
tural requirements of HS–FGF interactions. It has been shown that
the minimal HS sequence that can bind to FGF2 requires 2-O-sul-
fated IdoA and N-sulfated GlcN residues [11–13]. Highly sulfated
non-reducing end HS oligosaccharides were also found to bind
FGF-2 with a high afﬁnity [14]. Similarly, short, highly sulfated,
HS chains isolated from porcine liver and intestine could induce
FGF-2 mediated signaling efﬁciently [15]. However, while the
structure of the FGF binding motif has been discovered previously,lsevier B.V. All rights reserved.
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intact HS chain. One proposed model points to the existence of
GAGOSOMES – macromolecular enzyme complexes that reside
within the Golgi where HS biosynthetic enzymes act on nascent
HS chains to generate growth factor binding motifs [16,17]. How-
ever, it is unclear as to how these enzymes modify a growing HS
chain. Do all the enzymes in a GAGOSOME act concurrently or
sequentially on a growing HS chain to generate biologically active
structures?
In this study, we aim to elucidate the natural action of HS
biosynthetic enzymes by utilizing HS/FGF/FGFR interactions as
a tool. To do this, we prepared N-sulfated, epimerized and
2-O-sulfated HS structures by conducting enzymatic modiﬁca-
tions concurrently or sequentially. The resulting HS structures
were examined in a gel mobility shift assay to determine their
ability to form ternary complexes with FGF1 and FGFR1 or
FGFR2. The results of this study outline a snapshot of the seriesScheme 1. Concurrent and sequential action of HS biosof biosynthetic events that may take place in GAGOSOMES to
generate diverse HS structures.
2. Materials and methods
2.1. Materials
Recombinant HS biosynthetic enzymes, NDST-2, C5-epimerase
and 2-OST, were expressed using a baculovirus system and puriﬁed
as previously described [18]. Heparitinase I, II, and III were cloned
and expressed as previously described. Completely desulfated,
N-sulfated heparin 6 (CDSNS) was prepared as previously
described [19]. The heparosan polysaccharide 1was prepared from
Escherichia coli K5 strain as reported previously [20]. The DEAE-
sepharose gel was purchased from Amersham Biosciences. The
SAX column (250  4.6 mm, 5 lm particle size) was purchased
from Phenomenex Inc. [35S]Na2SO4 and Ultima-FloAP wereynthetic enzymes NDST, C5-epimerase and 2-OST.
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[35S]PAPS was prepared as reported earlier [21]. [32S]PAPS was pur-
chased from Sigma–Aldrich. HS disaccharide standards were pur-
chased from Iduron and Sigma–Aldrich. Human FGF1, FGFR1a
(IIIc) and FGFR2a (IIIc) were purchased from R&D Systems. All
other reagents and solvents were obtained from Sigma–Aldrich.
2.2. Preparation of N-sulfated, epimerized and 2-O-sulfated HS
polysaccharides
All reactions were performed in a buffer consisting of 25 mM
MES (pH 7.0), 0.02% Triton X-100, 2.5 mM MgCl2, 2.5 mM MnCl2,
1.25 mM CaCl2 and 0.75 mg/ml BSA [22]. In the concurrent reac-
tion, 20 lg of heparosan 1 was incubated with 10 ll each of
NDST-2, C5-epi and 2-OST (20 lg/ml), and with 5 ll of
[35S]PAPS(1  107CPM)/100 lg of [32S]PAPS in a 200 ll reaction.
The reaction was incubated for 24 h at 37 C. The reaction was ter-
minated by heating for 2 min at 96 C. The samples were diluted
with one volume of 0.016% Triton X-100 and loaded onto a mini
DEAE-sepharose column (0.3 ml) that had been pre-equilibrated
with 2 ml of wash buffer (20 mM NaOAc, 0.1 M NaCl and 0.01% Tri-
ton X-100, pH 6.0). After washing with 9 ml of wash buffer, the
bound polysaccharide was eluted with 1.8 ml of elution buffer
(20 mM NaOAc, 1 M NaCl, pH 6.0). The eluate was then desalted
and concentrated to 100 ll ﬁnal volume. In the sequential reaction,
20 lg of heparosan 1 was ﬁrst incubated with NDST-2 and
[32S]PAPS. The sample was puriﬁed, desalted, concentrated and
used as the substrate for the next reaction with C5-epimerase.
Finally, the resulting product was 2-O-sulfated by 2-OST in the
presence of [35S]PAPS/[32S]PAPS. CDSNS polysaccharide 6 was
2-O-sulfated by 2-OST in the presence of [35S]PAPS or [32S]PAPS
and the resulting product 7 was used as a control in the gel mobil-
ity shift assay.
2.3. Disaccharide analysis of the polysaccharides
Radioactive samples were digested with heparitinase I, II, and III
overnight at 37 C and analyzed using strong anion-exchange
(SAX)-HPLC coupled with an in-line radiometry/UV detector. The
disaccharides were eluted with a linear gradient of 0–800 mMNaCl
(pH 3.5) for 35 min and 2 M NaCl (pH 3.5) for 10 min. HS disaccha-
ride standards were co-injected and detected at 232 nm.
Non-radioactive samples were analyzed using liquid chromatogra-
phy–mass spectrometry (LC–MS). Disaccharides were separated on
a C18 column (0.3  250 mm, Vydac, USA) using a gradient from
0% to 100% of acetonitrile at a ﬂow rate of 5 ll/min over 70 min.Scheme 2. Enzymatic 2-O-sulfation o5 mM dibutylamine was used as an ion-pairing agent. Capillary
HPLC coupled to an electrospray ionization time-of-ﬂight MS (Bru-
ker Daltonics, USA) was used in the negative ion mode at the fol-
lowing conditions: cone gas 50 l/h, nozzle temperature 130 C,
drying gas (N2) ﬂow 450 l/h, spray tip potential 2.3 kV, and nozzle
potential 35 V.
2.4. Gel mobility shift assay
Enzymatically modiﬁed polysaccharide (1 lg), FGF (250 ng),
and FGFR (500 ng) were mixed in 20 ll of binding buffer
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 10mMMgCl2,
1.4 mMKH2PO4 and 12% glycerol) and incubated at 23 C for
30 min to facilitate complex formation [22]. The entire mixture
was loaded onto a native 4.5% polyacrylamide gel (20  25 cm).
The gel was subjected to electrophoresis at 100 V for 6 h at 4 C.
The gel was then dried, exposed to a phosphor screen overnight
and imaged by a Typhoon PhosphorImager system.
3. Results
The primary objective of the current study is to elucidate how
the FGF binding motif is generated in the Golgi. In order to deter-
mine whether the different modiﬁcations present in the FGF bind-
ing motif are created by enzymatic modiﬁcations that may occur
sequentially or concurrently, three different polysaccharides prod-
ucts were prepared in a sequential or concurrent approach as out-
lined in the Schemes 1 and 2 using biosynthetic enzymes:
(1) Polysaccharide 2: Heparosan 1was treated with NDST-2, C5-
Epimerase and 2-OST all together.
(2) Polysaccharide 5: Heparosan 1 was ﬁrst treated with NDST-
2, then C5-epimerase and followed ﬁnally by 2-OST.
(3) Polysaccharide 7: Completely desulfated, N-sulfated
(CDSNS) heparin 6 was treated with 2-OST in the presence
of [35S]PAPS to produce the polysaccharide 7 for use in the
control experiment.
Polysaccharides 2, 5 and 7 were characterized by SAX-HPLC
(Fig. 1) by comparing their disaccharide compositions with the
aid of co-injected disaccharide standards. While polysaccharide 2
had two radiolabeled disaccharides, DUA-GlcNS and DUA2S-
GlcNS, polysaccharide 5 had only one radiolabeled DUA2S-GlcNS
disaccharide because it was N-sulfated using non-radioactive
[32S]PAPS. Similarly, polysaccharide 7 only contained the radioac-
tive DUA2S-GlcNS disaccharide.f CDSNS-heparin polysaccharide.
Fig. 1. Disaccharide analysis of concurrently modiﬁed polysaccharide 2, sequen-
tially modiﬁed polysaccharide 5 and positive control polysaccharide 7. The
disaccharide peaks were determined with the aid of co-injected disaccharide
standards. (1) DUA-GlcNS, (2) DUA2S-GlcNS.
Fig. 3. Gel mobility shift assay to test the formation of the HS/FGF/FGFR ternary
complex. Polysaccharide 2, 5 and 7 were used in combinations with FGF1 (F1) and
FGFR1 (R1) or FGF1 and FGFR2 (R2). A shift in the mobility of radio-labeled
polysaccharides indicates ternary complex formation. Only polysaccharides 5 and 7
could form the ternary complex with FGF1/FGFR1 and FGF1/FGFR2.
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presence of [32S]PAPS so that we could utilize LC-MS analysis to
estimate the non-sulfated disaccharide content (Fig. 2). MS data
suggested that the amount of DUA2S-GlcNS disaccharide was sig-
niﬁcantly higher in both the sequentially modiﬁed polysaccharide
5 and the positive control polysaccharide 7 in comparison to the
concurrently modiﬁed polysaccharide 2.
Once the polysaccharides were characterized, they were tested
in a gel mobility shift assay to determine whether they could form
the ternary complex with FGF1 and FGFR1 or FGFR2 (Fig. 3). A shift
in the mobility of the radiolabeled-polysaccharide indicates theFig. 2. MS spectra of disaccharides from concurrently modiﬁed polysaccharide 2,
sequentially modiﬁed polysaccharide 5 and positive control polysaccharide 7. The
following disaccharides were detected: DUA-GlcNAc (m/z 378.1), DUA-GlcNS (m/z
416.0) and DUA2S-GlcNS (m/z 496.0).formation of the ternary complex. Based on the data shown in
Fig. 3, only polysaccharides 5 and 7 could form the ternary com-
plex signiﬁcantly with FGF1/FGFR1 and FGF1/FGFR2.
4. Discussion
The FGF family members play a major role in various biological
processes including organogenesis, wound healing, and nervous
system development and function [4]. Disrupted FGF signaling is
also present in a variety of human pathologies including Crouzon’s
syndrome, Pfeiffer’s syndrome, and Apert’s syndrome [3]. It is well
known that heparan sulfate acts as a co-receptor for FGF/FGFR
mediated cell signaling [8–10]. Various studies have reported that
both speciﬁc sulfation patterns and the extent of sulfation of HS are
key parameters that determine the formation of the HS/FGF/FGFR
ternary complex [11–13,15]. However, it is still unclear how the
FGF binding motif on HS is assembled in the Golgi. Therefore, this
work aims to elucidate whether the FGF binding motif is assem-
bled by enzyme actions that occur sequentially or concurrently.
In this investigation, three different enzymatically synthesized
polysaccharides were utilized for binding studies with FGF1 and
FGFRs. The obtained data conﬁrmed that NDST-2, C5-epimerase
and 2-OST can act on heparosan concurrently. When acting con-
currently, these enzymes did not generate a signiﬁcant amount
of the disulfated DUA2S-GlcNS disaccharide. However, when the
enzymes were added sequentially, this disaccharide was abundant
in the modiﬁed product.
After the structural characterization of the synthesized prod-
ucts, a gel mobility shift assay was performed with FGF1 and
FGFR1 or FGFR2 to determine which polysaccharides could form
the ternary complex. Surprisingly, only polysaccharides 5 and 7
could form the ternary complex with FGF1/FGFR1 and FGF1/FGFR2.
While it is possible that polysaccharide 2 may form a few weak
complexes that are intangible in this gel mobility shift assay, it is
evident that polysaccharide 5 has signiﬁcantly higher binding
afﬁnity compared to polysaccharide 2 resulting in tangible com-
plexes under the electrophoretic conditions. Differential binding
ability of these polysaccharides with FGF/FGFR may perhaps be
Fig. 4. Plausible schematic model of the assembly of FGF/FGFR binding HS motifs.
HS chains can form ternary complexes with FGF and FGFR only when they are
modiﬁed by HS biosynthetic enzymes in a sequential manner.
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such as surface plasmon resonance. Interestingly, an earlier study
has shown that more potent ATIII-binding HS anticoagulant struc-
ture is generated when HS biosynthetic enzymes act concurrently
[18]. The current study points to a fundamental difference in the
sulfation patterns produced by HS biosynthetic enzymes when
they act sequentially or concurrently on the polysaccharide back-
bone. Natural heparan sulfate has a domain-like organization
whereby some segments of the chain are highly sulfated (NS
domains), some segments have little to no sulfation (NA domains),
and some segments are partially sulfated (NA/NS domains). By
sequentially modifying heparosan, it is likely that the resulting
polysaccharides 5 and 7 have an extended sulfation pattern that
mimics natural HS whereas polysaccharide 2 has a more random
sulfation pattern that is not present in the natural FGF1-binding
HS domain. Furthermore, polysaccharide 2 was found to migrate
slower than polysaccharide 5 during gel electrophoresis, indicating
that the overall sulfation density of the polysaccharide 2 is much
less than that of the polysaccharides 5 and 7.
Based on the results from this study, we can predict that the
production of the FGF1/FGFR binding motif proceeds in a sequen-
tial manner in the Golgi. As the nascent HS chain passes through
GAGOSOMES, it is modiﬁed in a speciﬁc order by HS biosynthetic
enzymes (Fig. 4). However, the factors that modulate this orderly
action remain unknown. A number of factors can affect the order
of modiﬁcation including: the speciﬁc location of these enzymes,
the limited concentration of PAPS or the effect of sulfation patterns
on the enzymatic action of other sulfotransferases. Future studies
will further probe the biosynthesis of the FGF/FGFR binding motif
in HS by using ﬂuorescence assisted colocalization experiments
to track nascent HS chains as they are modiﬁed by GAGOSOMES.
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